Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Goksu SS"'
Autor:
Verlingue L; Gustave Roussy Institute of Oncology, Villejuif, France., Italiano A; Institut Bergonié Cancer Center, Bordeaux, France., Prenen H; Antwerp University Hospital, Edegem, Belgium., Guerra Alia EM; Ramón y Cajal University Hospital, Madrid, Spain., Tosi D; Montpellier Cancer Institute, Montpellier, France., Perets R; Division of Oncology, Clinical Research Institute at Rambam, Rambam Medical Center, Haifa, Israel., Lugowska I; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Moiseyenko V; Clinical Scientific and Practical Center, Saint-Petersburg, Russia., Gumus M; Istanbul Medeniyet University, Istanbul, Turkey., Arslan C; Izmir Economy University Medical Point Hospital, Izmir, Turkey., Lindsay CR; The Christie NHS Foundation Trust, Manchester, UK., Deva S; Auckland City Hospital, Auckland, New Zealand., Taus Á; Medical Oncology Department Hospital del Mar, CIBERONC, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Rottey S; Gent University Hospital, Gent, Belgium., Cicin I; Trakya University, Edirne, Turkey., Goksu SS; Akdeniz University, Antalya, Turkey., Smolin A; Burdenko Main Military Hospital, Moscow, Russia., Roselló-Keränen S; INCLIVA Biomedical Research Institute, Hospital Clinico Universitario de Valencia, Valencia, Spain., Habigt C; Roche Pharma Research and Early Development, Penzburg, Germany., Marbach D; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Boetsch C; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Dejardin D; Roche Product Development, Data Science, Roche Innovation Center, Basel, Switzerland., Sleiman N; Roche Product Development, Data Science, Roche Innovation Center, Basel, Switzerland., Evers S; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Richard M; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Ardeshir C; Roche Products Ltd, Welwyn Garden City, UK., Charo J; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Kraxner A; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Teichgräber V; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Keshelava N; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Dziadziuszko R; Medical University of Gdansk, Gdansk, Poland. Electronic address: rafal.dziadziuszko@gumed.edu.pl.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Nov; Vol. 109, pp. 105374. Date of Electronic Publication: 2024 Oct 11.
Autor:
Köstek O; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Demirel A; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Hacıoğlu MB; Department of Medical Oncology, Trakya University, Istanbul, Turkiye., Tastekin D; Department of Medical Oncology, Istanbul University, Istanbul, Turkiye., Karabulut S; Department of Medical Oncology, Istanbul University, Istanbul, Turkiye., Gündogdu A; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Sever N; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Ayhan M; Clinic of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkiye., Çelebi A; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Majidova N; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Yaşar A; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Ağyol Y; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Erel P; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Kocaaslan E; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Güren AK; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Arıkan R; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Isık S; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Ercelep O; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Goksu SS; Department of Medical Oncology, Antalya University, Antalya, Turkiye., Alandag C; Department of Medical Oncology, Cumhuriyet University, Sivas, Turkiye., Bilgetekin İ; Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkiye., Caner B; Department of Medical Oncology, Uludag University, Bursa, Turkiye., Sahin AB; Department of Medical Oncology, Uludag University, Bursa, Turkiye., Gulmez A; Faculty of Medicine, Department of Medical Oncology, Inonu University, Malatya, Turkey., Akagunduz B; Clinic of Medical Oncology, Mengucekgazi Training and Research Hospital, Erzincan, Turkiye., Kose F; Department of Medical Oncology, Baskent University, Adana, Turkiye., Kaplan MA; Department of Medical Oncology, Dicle University, Diyarbakir, Turkiye., Dogan E; Department of Medical Oncology, Erciyes University, Kayseri, Turkiye., Sakalar T; Department of Medical Oncology, Erciyes University, Kayseri, Turkiye., Guven DC; Department of Medical Oncology, Hacettepe University, Ankara, Turkiye., Gurbuz M; Department of Medical Oncology, Ankara University, Ankara, Turkiye., Ergun Y; Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkiye., Karaagac M; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkiye., Turker S; Clinic of Medical Oncology, Ankara Dışkapı Yıldırım Beyazıt Research and Training Hospital, Ankara, Turkiye., Ozkul O; Department of Medical Oncology, Sakarya University, Sakarya, Turkıye., Yıldız B; Department of Medical Oncology, Gülhane Training and Research Hospital, Ankara, Turkey., Sahin S; Department of Medical Oncology, Van Education and Research Hospital, Van, Turkey., Demiray AG; Department of Medical Oncology, Pamukkale University, Denizli, Turkiye., Sari M; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Erdogan B; Department of Medical Oncology, Trakya University, Istanbul, Turkiye., Hacıbekiroglu İ; Department of Medical Oncology, Sakarya University, Sakarya, Turkıye., Çakmak Öksüzoğlu ÖB; Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkiye., Kilickap S; Department of Medical Oncology, Hacettepe University, Ankara, Turkiye., Bilici A; Department of Medical Oncology, Medipol University, Istanbul, Turkiye., Bayoglu İV; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Topaloglu S; Department of Medical Oncology, Trakya University, Istanbul, Turkiye., Cicin İ; Department of Medical Oncology, Trakya University, Istanbul, Turkiye.
Publikováno v:
Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Nov; Vol. 36 (7), pp. 613-621. Date of Electronic Publication: 2024 Jan 23.
Autor:
Ozbay MF; Department of Medical Oncology, Kirsehir Training and Research Hospital Kirsehir 40100, Turkey., Cetinkaya AM; Department of Medical Oncology, Faculty of Medicine, Akdeniz University Antalya 07000, Turkiye., Balcik OY; Alanya Alaattin Keykubat University, Department of Medical Oncology Antalya, Türkiye., Ilhan Y; Antalya City Hospital, Department of Medical Oncology Antalya, Türkiye., Genc TB; Department of Medical Oncology, Mus State Hospital Mus 49250, Turkey., Goksu SS; Department of Medical Oncology, Faculty of Medicine, Akdeniz University Antalya 07000, Turkiye.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2024 Oct 25; Vol. 14 (10), pp. 5095-5104. Date of Electronic Publication: 2024 Oct 25 (Print Publication: 2024).
Autor:
Cheng Y; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Spigel DR; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Cho BC; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Laktionov KK; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Fang J; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Chen Y; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Zenke Y; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Lee KH; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Wang Q; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Navarro A; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Bernabe R; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Buchmeier EL; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Chang JW; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Shiraishi Y; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Goksu SS; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Badzio A; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Shi A; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Daniel DB; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Hoa NTT; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Zemanova M; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Mann H; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Gowda H; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Jiang H; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.)., Senan S; From Jilin Cancer Hospital, Changchun (Y. Cheng), Department II of Thoracic Oncology (J.F.) and the Department of Radiation Oncology (A.S.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, and the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou (Q.W.) - all in China; Sarah Cannon Research Institute (D.R.S.) and Tennessee Oncology (D.B.D.) - both in Nashville; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chungbuk National University Hospital, Cheongju (K.H.L.) - both in South Korea; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow (K.K.L.); Cancer and Hematology Centers of Western Michigan, Grand Rapids (Y. Chen); National Cancer Center Hospital East, Kashiwa (Y.Z.), and Kyushu University Hospital, Fukuoka (Y.S.) - both in Japan; Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona (A.N.), and Hospital Universitario Virgen del Rocio, Seville (R.B.) - both in Spain; Hospitals of the City of Cologne, Cologne, Germany (E.L.B.); Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan (J.W.-C.C.); Akdeniz University Medical Faculty, Antalya, Turkey (S.S.G.); Medical University of Gdansk, Gdansk, Poland (A.B.); National Cancer Hospital, Hanoi, Vietnam (N.T.T.H.); First Faculty of Medicine, Charles University, and General University Hospital, Prague, Czech Republic (M.Z.); AstraZeneca, Cambridge, United Kingdom (H.M.); AstraZeneca, Gaithersburg, MD (H.G., H.J.); and the Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam (S.S.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Oct 10; Vol. 391 (14), pp. 1313-1327. Date of Electronic Publication: 2024 Sep 13.
Autor:
Yasar HA; Medical Oncology Department, Ankara University, Ankara, Turkey., Aktas BY; Medical Oncology Department, Hacettepe University, Ankara, Turkey., Ucar G; Medical Oncology Department, Ankara Numune Training and Research Hospital, Ankara, Turkey., Goksu SS; Medical Oncology Department, Akdeniz University, Antalya, Turkey., Bilgetekin I; Medical Oncology Department, Gazi University, Ankara, Turkey., Cakar B; Medical Oncology Department, Ege University, Izmir, Turkey., Sakin A; Medical Oncology Department, Van Yuzuncu Yıl University, Van, Turkey., Ates O; Medical Oncology Department, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Basoglu T; Medical Oncology Department, Marmara University, Istanbul, Turkey., Arslan C; Medical Oncology Department, Bahcesehir University, MedicalPark Hospital, Izmir, Turkey., Demiray AG; Medical Oncology Department, Pamukkale University, Denizli, Turkey., Paydas S; Medical Oncology Department, Adana Cukurova University, Adana, Turkey., Cicin I; Medical Oncology Department, Trakya University, Edirne, Turkey., Sendur MAN; Medical Oncology Department, Ankara Yıldırım Beyazıt University, Ankara, Turkey., Karadurmus N; Medical Oncology Department, Gulhane Training and Research Hospital, Ankara, Turkey., Kosku H; Medical Oncology Department, Ankara University, Ankara, Turkey., Uner A; Medical Oncology Department, Gazi University, Ankara, Turkey., Yumuk PF; Medical Oncology Department, Marmara University, Istanbul, Turkey; Medical Oncology Department, Koç University, Istanbul; Turkey., Utkan G; Medical Oncology Department, Ankara University, Ankara, Turkey., Kefeli U; Medical Oncology Department, Kocaeli University, Kocaeli, Turkey., Tanriverdi O; Medical Oncology Department, Mugla Sıtkı Kocman University, Mugla, Turkey., Cinkir H; Medical Oncology Department, Gaziantep University, Gaziantep, Turkey., Gumusay O; Medical Oncology Department, Gaziosmanpasa University, Tokat, Turkey., Turhal NS; Medical Oncology Department, Anadolu Medical Center, Istanbul, Turkey., Menekse S; Medical Oncology Department, Manisa City Hospital, Manisa, Turkey., Kut E; Medical Oncology Department, Manisa City Hospital, Manisa, Turkey., Beypinar I; Medical Oncology Department, Afyon Health Sciences University, Afyon, Turkey., Sakalar T; Medical Oncology Department, Aksaray University, Aksaray, Turkey., Demir H; Medical Oncology Department, Afyon Health Sciences University, Afyon, Turkey., Yekeduz E; Medical Oncology Department, Ankara University, Ankara, Turkey., Kilickap S; Medical Oncology Department, Hacettepe University, Ankara, Turkey., Erman M; Medical Oncology Department, Hacettepe University, Ankara, Turkey., Urun Y; Medical Oncology Department, Ankara University, Ankara, Turkey. Electronic address: yuksel.urun@ankara.edu.tr.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun; Vol. 22 (3), pp. 102077. Date of Electronic Publication: 2024 Mar 15.
Autor:
Cicin I; İstinye University, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Türkiye., Karadurmus N; Gulhane Research & Training Hospital, Department of Internal Medicine, Division of Medical Oncology, Ankara, Türkiye., Bilici A; Medipol University, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Türkiye., Bahsi T; Ankara Etlik City Hospital, Department of Medical Genetics, Ankara, Türkiye., Sendur MA; Ankara Yıldırım Beyazıt University, Department of Internal Medicine, Division of Medical Oncology, Ankara, Türkiye., Demirci U; Memorial Ankara Hospital, Department of Internal Medicine, Division of Medical Oncology, Ankara, Türkiye., Goksu SS; Akdeniz Univesity, Department of Internal Medicine, Division of Medical Oncology, Antalya, Türkiye., Er O; Acıbadem University, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Türkiye., Bisgin A; Cukurova University, Department of Medical Genetics, Adana, Türkiye., Ozturk Saglam OF; Pfizer Pharmaceuticals, Medical Oncology Department, Istanbul, Türkiye., Aver B; Pfizer Pharmaceuticals, Medical Oncology Department, Istanbul, Türkiye., Kilickap S; Istinye University, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Türkiye.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 May; Vol. 20 (15), pp. 1031-1045. Date of Electronic Publication: 2023 Nov 28.
Autor:
Kahraman S; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey. sedakayacan.kahraman@gmail.com., Karakaya S; Department of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara, Turkey., Kaplan MA; Department of Medical Oncology, Dicle University Medical Faculty Hospital, Diyarbakir, Turkey., Goksu SS; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey., Ozturk A; Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey., Isleyen ZS; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey., Hamdard J; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey., Yildirim S; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Dogan T; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey., Isik S; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Celebi A; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Gulbagci BB; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey., Paksoy N; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Dogan M; Department of Medical Oncology, Ankara Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Turk HM; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey., Bilici A; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey., Tatli AM; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey., Akbas S; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey., Turan N; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Hacibekiroglu I; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey., Dogu GG; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey., Aydiner A; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Sumbul AT; Department of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Turkey., Akyurek S; Department of Radiation Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Yalciner M; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Demirkazik A; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Gursoy P; Department of Medical Oncology, Ege University Medical Faculty Hospital, Izmir, Turkey., Aykan MB; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey., Sahin E; Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, Turkey., Karadag İ; Department of Medical Oncology, Hittite University Corum Training and Research Hospital, Corum, Turkey., Kostek O; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Er MM; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey., Artaç M; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey., Duzkopru Y; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey., Aydin D; Department of Medical Oncology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey., Isik D; Department of Medical Oncology, Kocaeli Medical Park Hospital, Kocaeli, Turkey., Karakas Y; Department of Medical Oncology, Acıbadem Bodrum Hospital, Mugla, Turkey., Kilickap S; Department of Medical Oncology, Liv Hospital, Istinye University, Ankara, Turkey., Erol C; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey., Demir B; Department of Medical Oncology, Aydin Ataturk State Hospital, Aydin, Turkey., Civelek B; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey., Ergun Y; Department of Medical Oncology, Batman Training and Research Hospital, Batman, Turkey., Akinci MB; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey., Dogan I; Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey., Karadurmus N; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey., Yumuk PF; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey., Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Publikováno v:
Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5820. Date of Electronic Publication: 2024 Mar 09.
Autor:
Bilici A; Medical Faculty, Department of Medical Oncology, Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi, No:1, Bagcilar, 34214, Istanbul, Turkey. ahmetknower@yahoo.com., Koca S; Medical Faculty, Department of Medical Oncology, Marmara University, Istanbul, Turkey., Karaagac M; Meram Medical Faculty, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Aydin SG; Medical Faculty, Department of Medical Oncology, Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi, No:1, Bagcilar, 34214, Istanbul, Turkey., Eraslan E; Department of Medical Oncology, Dr.Abdurrahman Yurtarslan Oncology Education and Research Hospital, Ankara, Turkey., Kaplan MA; Medical Faculty, Department of Medical Oncology, Dicle University, Diyarbakir, Turkey., Ocak B; Medical Faculty, Department of Medical Oncology, UludagUniversity, Bursa, Turkey., Goksu SS; Medical Faculty, Department of Medical Oncology, Akdeniz University, Antalya, Turkey., Paydas S; Medical Faculty, Department of Medical Oncology, Cukurova University, Adana, Turkey., Akgul F; Medical Faculty, Department of Medical Oncology, Trakya University, Edirne, Turkey., Derin S; Cerrahpasa Medical Faculty, Department of Medical Oncology, Istanbul University-Cerrahpasa, Istanbul, Turkey., Ergun Y; Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey., Yekeduz E; Medical Faculty, Department of Medical Oncology, Ankara University, Ankara, Turkey., Erol C; Medical Faculty, Department of Medical Oncology, Ankara Yildirim Beyazit University, Ankara, Turkey., Ozyukseler DT; Department of Medical Oncology, Dr. Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey., Demiray AG; Medical Faculty, Department of Medical Oncology, Pamukkale University, Denizli, Turkey., Karaca M; Department of Medical Oncology, Antalya Kartal Education and Research Hospital, Antalya, Turkey., Guc ZG; Medical Faculty, Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkey., Menekse S; Department of Medical Oncology, Manisa State Hospital, Manisa, Turkey., Cinkir HY; Medical Faculty, Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey., Gumusay O; Medical Faculty, Department of Medical Oncology, Acibadem University, Istanbul, Turkey., Sakin A; Medical Faculty, Department of Medical Oncology, Yuzuncuyil University, Van, Turkey., Ozkul O; Department of Medical Oncology, Sakarya Education and Research Hospital, Sakarya, Turkey., Demir H; Medical Faculty, Department of Medical Oncology, Afyon Kocatepe University, Afyon, Turkey., Erdem D; Medical Faculty, Department of Medical Oncology, Bahcesehir University, Samsun, Turkey., Besiroglu M; Medical Faculty, Department of Medical Oncology, Bezmialem Vakif University, Istanbul, Turkey., Unal OU; Department of Medical Oncology, Izmir Bozyaka Education and Research Hospital, Izmir, Turkey., Acar R; Department of Medical Oncology, Gulhane Education and Research Hospital, Ankara, Turkey., Koral L; Medical Faculty, Department of Medical Oncology, Canakkale Onsekiz Mart University, Canakkale, Turkey., Sahin S; Department of Medical Oncology, Van Education and Research Hospital, Van, Turkey., Sakalar T; Department of Medical Oncology, Aksaray Education and Research Hospital, Aksaray, Turkey., Bahceci A; Department of Medical Oncology, Gaziantep Dr. Ersin Arslan Education and Research Hospital, Gaziantep, Turkey., Ozveren A; Department of Medical Oncology, Giresun Prof. Dr. A. Ilhan Ozdemir Education and Research Hospital, Giresun, Turkey., Gunaydin UM; Medical Faculty, Department of Medical Oncology, Istanbul Medeniyet University, Istanbul, Turkey., Seker MM; Department of Medical Oncology, Ankara Koru Hospital, Ankara, Turkey., Sunar V; Department of Medical Oncology, Zekai Tahir Burak Education and Research Hospital, Ankara, Turkey., Dal P; Department of Medical Oncology, Eskisehir Education and Research Hospital, Eskisehir, Turkey., Artac M; Meram Medical Faculty, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Turhal S; Anadolu Medical Center, Department of Medical Oncology, Istanbul, Turkey.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Sep; Vol. 149 (11), pp. 8243-8253. Date of Electronic Publication: 2023 Apr 17.
Autor:
Hacioglu MB; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Erdogan B; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Bardakcı M; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Algın E; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Gulbagcı B; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Hacibekiroglu I; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Hamdard J; Department of Medical Oncology, Faculty of Medicine, Medipol University, İstanbul, Turkey., Olmez OF; Department of Medical Oncology, Faculty of Medicine, Medipol University, İstanbul, Turkey., Akkus H; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey., Oksuzoglu B; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey., Goksu SS; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Dae SA; Department of Medical Oncology, Faculty of Adana Medicine, Baskent University, Adana, Turkey., Sumbul AT; Department of Medical Oncology, Faculty of Adana Medicine, Baskent University, Adana, Turkey., Ugraklı M; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Karaagac M; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Sahin E; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey., Cabuk D; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey., Ozer O; Department of Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey., Yavuzsen T; Department of Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey., Arıkan R; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Köstek O; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Atcı MM; Department of Medical Oncology, Prof. Dr. Cemil Tascıoglu City Hospital, Istanbul, Turkey., Sakin A; Department of Medical Oncology, Prof. Dr. Cemil Tascıoglu City Hospital, Istanbul, Turkey., Deligonul A; Department of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey., Bayır D; Department of Medical Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey., Dincer M; Department of Medical Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey., Unsal O; Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey., Yazıcı O; Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey., Zeynelgil E; Department of Medical Oncology, Diskapi Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey., Gulmez A; Department of Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey., Harputluoglu H; Department of Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey., Erol C; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazit University, Ankara, Turkey., Sendur MAN; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazit University, Ankara, Turkey., Aytekin A; Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey., Akagunduz B; Department of Medical Oncology, Mengucek Gazi Education and Research Hospital, Erzincan Binali Yıldırım University, Erzincan, Turkey., Oner I; Department of Medical Oncology, Konya City Hospital, Konya, Turkey., Er O; Department of Medical Oncology, Maslak Hospital, Acıbadem MAA University, Istanbul, Turkey., Oztosun B; Department of Medical Oncology, Goztepe Education and Research Hospital, Medeniyet University, Istanbul, Turkey., Gumus M; Department of Medical Oncology, Goztepe Education and Research Hospital, Medeniyet University, Istanbul, Turkey., Selçukbiricik F; Department of Medical Oncology, Koc University Hospital, Istanbul, Turkey., Aykan MB; Department of Medical Oncology, Ankara Gulhane Education and Research Hospital, Ankara, Turkey., Karadurmus N; Department of Medical Oncology, Ankara Gulhane Education and Research Hospital, Ankara, Turkey., Degerli E; Department of Medical Oncology, Faculty of Medicine, Cerrahpasa University, Istanbul, Turkey., Demirci NS; Department of Medical Oncology, Faculty of Medicine, Cerrahpasa University, Istanbul, Turkey., Turkmen E; Department of Medical Oncology, Derince Education and Research Hospital, Kocaeli, Turkey., Şakalar T; Department of Medical Oncology, Kahramanmaras Necip Fazıl City Hospital, Kahramanmaras, Turkey., Secmeler S; Department of Medical Oncology, Sanlıurfa Mehmet Akif İnan Education and Research Hospital, Şanlıurfa, Turkey., Tanrıverdi O; Department of Medical Oncology, Faculty of Medicine, Mugla Sıtkı Kocman University, Mugla, Turkey., Alkan A; Department of Medical Oncology, Faculty of Medicine, Mugla Sıtkı Kocman University, Mugla, Turkey., Kemal Y; Department of Medical Oncology, Faculty of Medicine, Altınbas University, Samsun, Turkey., Cil I; Department of Medical Oncology, Istanbul Umraniye Education and Research Hospital, Istanbul, Turkey., Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul Bilim University, Istanbul, Turkey., Iriagaç Y; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namık Kemal University, Tekirdag, Turkey., Alan O; Department of Medical Oncology, Tekirdag City Hospital, Tekirdag, Turkey., Balli S; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Urun Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Ozcan E; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Turhal NS; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Cicin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Publikováno v:
Head & neck [Head Neck] 2023 Jul; Vol. 45 (7), pp. 1643-1653. Date of Electronic Publication: 2023 Apr 21.
Autor:
Ilhan RG; Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey., Ilhan Y; Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey., Goksu SS; Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey., Tatli AM; Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey., Coskun HS; Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Publikováno v:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr; Vol. 19 (Supplement), pp. S0.